An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia

Objective: Trastuzumab (Herceptin®), a recombinant, humanized, monoclonal antibody targeting HER2 is well established as an effective treatment for HER2-positive breast cancer. Evidence from developed countries showed that trastuzumab was cost-effective; but there are few evidences in developing cou...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Biomédica
मुख्य लेखकों: Jefferson Antonio Buendía, Carlos Vallejos, Andrés Pichón-Rivière
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Instituto Nacional de Salud 2013
विषय:
Medicina
Positive
Colombia
Breast cancer
Human Epidermal Growth Factor Receptor 2
ऑनलाइन पहुंच:https://www.redalyc.org/articulo.oa?id=84329151010
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन